DyNAbind and Almirall enter new collaboration

posted in: Uncategorized | 0

Dresden/Barcelona, 18 May 2020. DyNAbind GmbH and Almirall, a leading skin-health focused pharmaceutical company based in Barcelona (Spain) have entered into a collaboration for compound screening based on DyNAbind’s proprietary DNA-encoded library (DEL) technology. This new partnership aims at discovering … Continued

DyNAbind Closes Financing Round

posted in: Uncategorized | 0

We’re happy to announce that DyNAbind has now closed its latest financing round with investment from the High-Tech Gründerfonds (HTGF), Technologie Gründerfonds Sachsen (TGFS) and the Technische Universität Dresden AG (TUDAG). HTGF and TGFS are institutional investors with strong track … Continued

1 2 3